Price
Target price
€15.30
€15.30
-3.160%
-0.5
-3.160%
€9.51
07.07.26 / Stuttgart Stock Exchange
WKN: 897013 / Symbol: IART / Name: Integra / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Integra LifeSciences Holdings Corp Stock
Integra LifeSciences Holdings Corp took a tumble today and lost -€0.500 (-3.160%).
Our community is currently low on Integra LifeSciences Holdings Corp with 1 Buy predictions and 5 Sell predictions.
This results in a negative potential of -41.18% based on a current price of 15.3 € and a target price of 9 € for the stock.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | -3.160% | 0.000% | 6.803% | 37.719% | 48.113% | -57.104% | -72.931% |
| Bio-Rad Labs Inc. A | -0.780% | -0.078% | 0.392% | 21.517% | -0.582% | -27.159% | -55.409% |
| CONMED Corp. | -2.580% | 7.746% | 0.658% | -33.188% | -12.571% | -74.068% | -73.621% |
| Penumbra Inc | -0.650% | 0.362% | -0.216% | 31.874% | 4.054% | -6.980% | 18.766% |
Comments
Integra LifeSciences (IART) was upgraded by Argus from "hold" to "buy". They now have a $25.00 price target on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (IART) had its price target raised by Citigroup Inc. from $9.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (IART) had its price target lowered by Citigroup Inc. from $11.00 to $9.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
News
Integra Resources Q1 Earnings Call Highlights
Integra Resources (NYSEAMERICAN:ITRG) reported first-quarter 2026 results that management said reflected a deliberate reinvestment phase at its Florida Canyon mine, alongside continued permitting
